SCHEMBL26488237

SCHEMBL26488237

CCCCCCCCN(CCCCCCCC)C(C(=O)O)c1cccs1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 1/20 0.40
HDAC11 Q96DB2 1/20 0.40
HDAC8 Q9BY41 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
NPC1 O15118 1/20 0.39
JAK2 O60674 1/20 0.39
RAB9A P51151 1/20 0.39
PAX8 Q06710 1/20 0.39
ALOX5 P09917 1/20 0.38
TP53 P04637 2/20 0.38
LMNA P02545 1/20 0.38
POLB P06746 1/20 0.38
THRB P10828 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
ICMT O60725 1/20 0.37
ALB P02768 1/20 0.37
CYP2C19 P33261 1/20 0.36
HDAC3 O15379 1/20 0.36
MAPK1 P28482 1/20 0.35
OPRM1 P35372 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26488234 0.76 ALOX5 (0.36) HDAC1HDAC11HDAC8HDAC6NPC1
SCHEMBL9000597 0.75 HDAC1 (0.43) HDAC1HDAC11HDAC8HDAC6ALOX5
SCHEMBL9093734 0.75 HDAC1 (0.43) HDAC1HDAC11HDAC8HDAC6ALOX5
SCHEMBL26488286 0.74 GPR84 (0.39) NPC1JAK2RAB9APAX8ICMT
SCHEMBL26488291 0.74 GPR84 (0.39) NPC1JAK2RAB9APAX8ICMT
SCHEMBL755753 0.74 ALOX5 (0.47) NPC1RAB9AALOX5TP53LMNA
SCHEMBL26488189 0.73 L3MBTL1 (0.45) NPC1JAK2RAB9APAX8ALOX5
SCHEMBL13193319 0.72 SOAT2 (0.43) HDAC1HDAC11HDAC8HDAC6ALOX5
SCHEMBL26109928 0.72 TSHR (0.36) HDAC1HDAC11HDAC8HDAC6NPC1
SCHEMBL28170178 0.72 HTT (0.45) HDAC1HDAC11HDAC8HDAC6ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230322689-A1 IONIZABLE LIPID COMPOUNDS AND LIPID NANOPARTICLE COMPOSITIONS SunVax mRNA Therapeutics Inc. (US) 2023-10-12 US disclosed
US-20230322689-A1 IONIZABLE LIPID COMPOUNDS AND LIPID NANOPARTICLE COMPOSITIONS SunVax mRNA Therapeutics Inc. (US) 2023-10-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230322689-A1 IONIZABLE LIPID COMPOUNDS AND LIPID NANOPARTICLE COMPOSITIONS PHOSPHO1, SGMS1, PLIN3 HDAC1 603/4885HDAC11 420/4885HDAC8 800/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.